Bioverge
Overview
Bioverge is a venture capital firm and investment platform founded in 2016 that specializes in early-stage healthcare startups operating at the intersection of biology and technology. The firm provides accredited investors with access to curated investment opportunities through deal-by-deal investments, diversified access funds, and thematic funds focused on specific disease areas. Bioverge's mission is to democratize access to healthcare investing, funding visionary entrepreneurs and allowing individuals to invest in companies tackling significant health challenges. It also operates an equity crowdfunding platform, Bioverge Portal, to include non-accredited investors.
Portfolio Companies
16
Website
bioverge.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Repair Biotechnologies | Nov 2025 | Seed | Co-investor |
| EnClear Therapies | Sep 2024 | VC Round | Co-investor |
| UberDoc Health Technologies Corp. | Jul 2024 | Seed | Lead |
| My Diabetes Tutor | Jul 2023 | Seed | Co-investor |
| Repair Biotechnologies | Jun 2023 | Series A | Co-investor |
Key People
Neil Littman
Founder General Partner
Rick Gibb
Co-Founder Investment Partner COO
Cody J. Locke
Investor
Parth Amin
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
